APAC Infectious Disease Diagnosis Treatment Market

ID: MRFR/MED/0814-HCR
80 Pages
Vikita Thakur
Last Updated: April 06, 2026
Asia Pacific Infectious Disease Diagnosis & Treatment Market Research Report, By Applications (AIDS, Tuberculosis (TB), Hepatitis, HPV, And Others), By Treatment (Antibiotics, Antivirals, Antifungals, Anti-Parasitic, Alternative Medicine And Others), By Diagnostic Techniques (Immunoassays, PCR, Cell Cultures And Other), By End Users (Hospitals, Clinics, Reference Labs And Others) - Forecast Till 2035
APAC Infectious Disease Diagnosis Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)2.27%
2024 Market Size$ 28.5 Billion
2025 Market Size$ 29.15 Billion
2035 Market Size$ 36.5 Billion
Key Players
Abbott Laboratories
Roche Holding AG
Thermo Fisher Scientific
Siemens Healthineers AG
Becton Dickinson and Company
bioMérieux SA
Trends
  • Advancements in Diagnostic Technologies
  • Increased Government Investment
  • Rise of Telemedicine Solutions
Opportunities
  • Rising Healthcare Expenditure
  • Growing Burden of Infectious Diseases
  • Technological Innovations in Diagnostics
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Industrial Automation & Equipment, BY Diagnosis Method (USD Billion)
      1. 4.1.1 Molecular Diagnostics
      2. 4.1.2 Serological Tests
      3. 4.1.3 Rapid Diagnostic Tests
      4. 4.1.4 Culture Methods
    2. 4.2 Industrial Automation & Equipment, BY Treatment Type (USD Billion)
      1. 4.2.1 Antibiotics
      2. 4.2.2 Antivirals
      3. 4.2.3 Vaccines
      4. 4.2.4 Antifungals
    3. 4.3 Industrial Automation & Equipment, BY Infectious Disease Type (USD Billion)
      1. 4.3.1 Bacterial Infections
      2. 4.3.2 Viral Infections
      3. 4.3.3 Fungal Infections
      4. 4.3.4 Parasitic Infections
    4. 4.4 Industrial Automation & Equipment, BY End User (USD Billion)
      1. 4.4.1 Hospitals
      2. 4.4.2 Clinical Laboratories
      3. 4.4.3 Home Care Settings
      4. 4.4.4 Research Institutes
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Abbott Laboratories (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 Roche Holding AG (CH)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Thermo Fisher Scientific Inc. (US)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Siemens Healthineers AG (DE)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Becton Dickinson and Company (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 bioMérieux SA (FR)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 Cepheid (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Hologic Inc. (US)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
      9. 5.2.9 QuidelOrtho Corporation (US)
        1. 5.2.9.1 Financial Overview
        2. 5.2.9.2 Products Offered
        3. 5.2.9.3 Key Developments
        4. 5.2.9.4 SWOT Analysis
        5. 5.2.9.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 APAC MARKET ANALYSIS BY DIAGNOSIS METHOD
    3. 6.3 APAC MARKET ANALYSIS BY TREATMENT TYPE
    4. 6.4 APAC MARKET ANALYSIS BY INFECTIOUS DISEASE TYPE
    5. 6.5 APAC MARKET ANALYSIS BY END USER
    6. 6.6 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
    7. 6.7 RESEARCH PROCESS OF MRFR
    8. 6.8 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
    9. 6.9 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    10. 6.10 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
    11. 6.11 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
    12. 6.12 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS METHOD, 2024 (% SHARE)
    13. 6.13 INDUSTRIAL AUTOMATION & EQUIPMENT, BY DIAGNOSIS METHOD, 2024 TO 2035 (USD Billion)
    14. 6.14 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT TYPE, 2024 (% SHARE)
    15. 6.15 INDUSTRIAL AUTOMATION & EQUIPMENT, BY TREATMENT TYPE, 2024 TO 2035 (USD Billion)
    16. 6.16 INDUSTRIAL AUTOMATION & EQUIPMENT, BY INFECTIOUS DISEASE TYPE, 2024 (% SHARE)
    17. 6.17 INDUSTRIAL AUTOMATION & EQUIPMENT, BY INFECTIOUS DISEASE TYPE, 2024 TO 2035 (USD Billion)
    18. 6.18 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 (% SHARE)
    19. 6.19 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USER, 2024 TO 2035 (USD Billion)
    20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 APAC MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY DIAGNOSIS METHOD, 2025-2035 (USD Billion)
      2. 7.2.2 BY TREATMENT TYPE, 2025-2035 (USD Billion)
      3. 7.2.3 BY INFECTIOUS DISEASE TYPE, 2025-2035 (USD Billion)
      4. 7.2.4 BY END USER, 2025-2035 (USD Billion)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

APAC Infectious Disease Diagnosis Treatment Market Segmentation

APAC Infectious Disease Diagnosis Treatment Market By Diagnosis Method (USD Billion, 2025-2035)

  • Molecular Diagnostics
  • Serological Tests
  • Rapid Diagnostic Tests
  • Culture Methods

APAC Infectious Disease Diagnosis Treatment Market By Treatment Type (USD Billion, 2025-2035)

  • Antibiotics
  • Antivirals
  • Vaccines
  • Antifungals

APAC Infectious Disease Diagnosis Treatment Market By Infectious Disease Type (USD Billion, 2025-2035)

  • Bacterial Infections
  • Viral Infections
  • Fungal Infections
  • Parasitic Infections

APAC Infectious Disease Diagnosis Treatment Market By End User (USD Billion, 2025-2035)

  • Hospitals
  • Clinical Laboratories
  • Home Care Settings
  • Research Institutes

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.